Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0000091,BDIX,male,200 days,57,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,55,%,0.8941,6.75,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98142,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,both,200 days,100,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,24,%,0.45,4.5,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98147,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,male,200 days,39,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,22,%,1.1209,7.0,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98148,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0000091,BDIX,female,200 days,52,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,41,%,1.0747,7.75,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98143,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0000091,BDIX,both,200 days,109,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,49,%,0.4789,5.0,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98144,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,male,200 days,51,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,38,%,1.0502,7.5,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98145,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,female,200 days,49,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,10,%,0.4643,3.25,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98146,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,female,200 days,47,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,26,%,0.6929,4.75,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98149,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,both,200 days,86,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,25,%,0.4583,4.25,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98150,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004790,BDIX.BDIV-D6Rat132-D6Rat229/Zte,both,200 days,24,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,19,%,1.7351,8.5,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98151,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,male,200 days,56,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,25,%,0.8018,6.0,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98152,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,female,200 days,62,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,26,%,0.7303,5.75,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98153,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,both,200 days,118,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,SD approximated from 95%CI,,25,%,0.3682,4.0,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98154,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0000089,BDIV,male,200 days,63,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,,,0,%,,,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98155,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0000089,BDIV,female,200 days,49,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,,,0,%,,,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98156,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",trigeminal nerve integrity trait,,RS:0000089,BDIV,both,200 days,112,,CMO:0002016,percentage of study population displaying trigeminal nerve neurilemmomas at a point in time,,,,0,%,,,MMO:0000163,in vivo visual assessment,,0.0,inferred from Kaplan-Meier plot analysis,,,,N-ethyl-N-nitrosourea (80 ug/g) ,98157,N-ethyl-N-nitrosourea (80 ug/g) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,both,254 days to 214 days,100,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,234,d,1.0,10.0,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98130,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000091,BDIX,male,213 days to 181 days,57,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,197,d,1.0596,8.0,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98125,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000091,BDIX,female,236 days to 192 days,52,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,214,d,1.5254,11.0,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98126,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000091,BDIX,both,213 days to 190 days,109,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,201,d,0.5508,5.75,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98127,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,male,258 days to 190 days,51,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,224,d,2.3805,17.0,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98128,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,female,340 days to 218 days,49,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,279,d,4.3571,30.5,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98129,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,male,250 days to 212 days,39,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,231,d,1.5212,9.5,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98131,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,female,269 days to 201 days,47,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,235,d,2.4797,17.0,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98132,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,both,237 days to 227 days,86,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,232,d,0.2696,2.5,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98133,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004790,BDIX.BDIV-D6Rat132-D6Rat229/Zte,both,0 days,24,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,,median,227,d,,,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98135,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,male,235 days to 209 days,56,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,222,d,0.5679,4.25,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98136,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,female,257 days to 215 days,62,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,236,d,1.3335,10.5,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98137,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,both,237 days to 220 days,118,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,SD approximated from 95%CI,median,228,d,0.3912,4.25,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98138,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000089,BDIV,male,0 days,63,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,,median,593,d,,,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98139,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000089,BDIV,female,0 days,49,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,,median,482,d,,,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98140,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000089,BDIV,both,0 days,112,,CMO:0003874,post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors,Kaplan Meier estimate,,median,593,d,,,MMO:0000344,necropsy,,0.0,,,,,N-ethyl-N-nitrosourea (80 mg/kg) ,98141,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000091,BDIX,male,200 days,57,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,45,%,0.6623,5.0,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98158,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000091,BDIX,female,200 days,52,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,59,%,1.0747,7.75,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98159,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000091,BDIX,both,200 days,109,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,51,%,0.4789,5.0,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98160,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,male,200 days,51,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,62,%,1.0502,7.5,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98161,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,female,200 days,49,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,90,%,0.6429,4.5,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98162,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004304,BDIX.BDIV-D6Mit1-D6Mgh2/Zte,both,200 days,100,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,76,%,0.45,4.5,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98163,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,male,200 days,39,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,78,%,1.1209,7.0,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98164,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,female,200 days,47,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,74,%,0.6929,4.75,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98165,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004305,BDIX.BDIV-D6Rat132-D6Mgh3/Zte,both,200 days,86,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,75,%,0.4583,4.25,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98166,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004790,BDIX.BDIV-D6Rat132-D6Rat229/Zte,both,200 days,24,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,80,%,1.7861,8.75,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98167,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,male,200 days,56,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,75,%,0.8018,6.0,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98168,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,female,200 days,62,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,74,%,0.7303,5.75,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98169,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0004306,BDIX.BDIV-D6Mit8-D6Rat229/Zte,both,200 days,118,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,75,%,0.3682,4.0,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98170,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000089,BDIV,male,200 days,63,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,100,%,,,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98171,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000089,BDIV,female,200 days,49,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,100,%,,,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98172,N-ethyl-N-nitrosourea (80 mg/kg) 2018,"van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28.",life span trait,,RS:0000089,BDIV,both,200 days,112,,CMO:0003873,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time,,ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873),,100,%,,,MMO:0000163,in vivo visual assessment,,0.0,PI time in S1,ENU injection,200,days,N-ethyl-N-nitrosourea (80 mg/kg) ,98173,N-ethyl-N-nitrosourea (80 mg/kg)